Clinical Trials Insight: 700027231
Phase of Trial: Phase II
Latest Information Update: 21 May 2008
At a glance
- Drugs Iroxanadine (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors CytRx Corporation
- 21 May 2008 The planned start for this trial is now the first quarter of 2009, according to a CytRx media release.
- 23 Jan 2008 The planned start for this trial has been moved to the second half of 2008, according to a CytRx Corporation media release, to allow for the development of a manufacturing process.
- 01 Oct 2007 New trial record.